Clinical Pharmacology in Athletic Training

Author:   Michelle Cleary ,  Tom Abdenour ,  Mike Pavlovich
Publisher:   Human Kinetics Publishers
ISBN:  

9781492594185


Pages:   368
Publication Date:   22 October 2021
Recommended Age:   From 18 to 99 years
Format:   Paperback
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $234.96 Quantity:  
Add to Cart

Share |

Clinical Pharmacology in Athletic Training


Add your own review!

Overview

Graduate-level resource for athletic training courses in pharmacology; reference for athletic trainers and health care providers working in sports medicine.

Full Product Details

Author:   Michelle Cleary ,  Tom Abdenour ,  Mike Pavlovich
Publisher:   Human Kinetics Publishers
Imprint:   Human Kinetics
Weight:   1.021kg
ISBN:  

9781492594185


ISBN 10:   1492594180
Pages:   368
Publication Date:   22 October 2021
Recommended Age:   From 18 to 99 years
Audience:   College/higher education ,  Tertiary & Higher Education
Format:   Paperback
Publisher's Status:   Active
Availability:   In stock   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Part I. Foundational Pharmacology Concepts Chapter 1. Legal Aspects of Therapeutic Medication Management Health Care Providers With Prescribing Authority The Sports Medicine Team Federal and State Laws Drug Development, Studies, and Standards Summary Case Studies Chapter 2. Administering Medications in the Athletic Training Setting Athletic Training Clinic Guidelines for Administering Medications Preventing Medication Errors Summary Case Studies Chapter 3. Drug Names, Classification, and Safety Drug Names Drug Classes Drug Safety Adverse Drug Effects and Therapeutic Monitoring Allergic Drug Reactions Medication Use Process Drug Information Resources Summary Case Studies Chapter 4. Pharmacokinetics Biopharmaceutics Drug Liberation Drug Absorption Drug Distribution Drug Metabolism Drug Elimination Pharmacokinetics and Exercise Summary Case Studies Chapter 5. Pharmacodynamics Mechanism of Action Drug Receptors Drug–Receptor Binding Drug–Receptor Interactions Drug Dosing Dose Responses Summary Case Studies Chapter 6. Drug Delivery, Dosages, and Procedures Drug Delivery Systems Routes of Administration Enteral Drug Delivery Parenteral Drug Delivery Mucous Membrane Drug Administration Topical Drug Administration Transdermal Drug Administration Medication Dosing Clinical Procedures for Enteral Drug Administration Summary Case Studies Part II. Classes of Therapeutic Medications Chapter 7. Drugs to Treat Pain: Nonopioid Analgesics and Anesthetics Biopsychosocial Model Differentiation of Pain Pathophysiology of Pain Analgesics Nonopioid Analgesic Agents Local Anesthetics Topical Analgesics: Creams, Gels, and Ointments The ATs’ Role in the Clinical Management of Pain Summary Case Studies Chapter 8. Drugs to Treat Pain: Opioid Analgesics Appropriate Use of Opioid Analgesics Classes of Opioid Analgesics Summary Case Studies Chapter 9. Drugs to Treat Inflammation: Steroidal and Nonsteroidal Anti-Inflammatories Inflammatory Process Controlling Inflammation Corticosteroids Nonsteroidal Anti-Inflammatory Drugs Summary Case Studies Chapter 10. Drugs to Treat Infection: Antibiotics Indications for Use Mechanism of Action Therapeutic Effects Routes of Administration Pharmacokinetics Pharmacodynamics Dosing Guidelines Adverse Effects Indications and Precautions Patient Education for Use of Antibacterial Medications Summary Case Studies Part III. Drugs for Treating Common Conditions Chapter 11. Drugs for Treating Asthma and Other Respiratory Conditions Respiratory Infections Allergic Rhinitis and Other Allergies Asthma Summary Case Studies Chapter 12. Drugs for Treating Cardiovascular Conditions Ischemic Chest Pain: Angina Pectoris Atherosclerosis and Coronary Artery Disease Acute Coronary Syndrome Hypertension and Hypertensive Crisis Cardiac Arrhythmias Thromboembolisms Summary Case Studies Chapter 13. Drugs for Treating Diabetes and Disordered Glucose Metabolism Glucose Homeostasis Metabolic Disorders Antidiabetic Agents for Managing Type 2 Diabetes Mellitus Insulin for Managing Type 1 and Type 2 Diabetes Mellitus Diabetes Care Plan Summary Case Studies Chapter 14. Drugs for Treating Digestive Disorders Nausea and Vomiting Diarrhea Constipation Gastroesophageal Reflux Disease Gastritis and Peptic Ulcer Disease Gastroenteritis Functional Bowel Disorders: Inflammatory Bowel Disease Supportive Care and General Management of Digestive Disorders Summary Case Studies Chapter 15. Drugs for Treating Common Musculoskeletal and Neurological Conditions Articular (Joint) Pain Musculotendinous Pain Neck and Back Pain Fibromyalgia Complex Regional Pain Syndrome Headache Disorders Summary Case Studies Chapter 16. Drugs for Treating Dermatological Conditions Protective Barrier of the Skin Principles of Topical Dermatologic Pharmacology Bacterial Skin and Soft-Tissue Infections Fungal Skin Infections Candidiasis Viral Skin Infections: Herpes Simplex and Molluscum Contagiosum Autoimmune Inflammatory Skin Conditions Summary Case Studies Chapter 17. Drugs for Treating Reproductive and Genitourinary Concerns Family Planning and Contraception Short-Acting Hormonal Contraceptives Long-Acting Reversible Contraception Barrier Methods Emergency Contraception Recommendations for Exercise During Pregnancy Sexually Transmitted Infections Reproductive and Urogenital Concerns Summary Case Studies Chapter 18. Drugs for Treating Mental Health Conditions Mental Health Conditions Behavioral Health Emergencies Treatment Options for Mental Health Disorders Mood Disorders Anxiety Disorders Stressor-Related Disorders Sleep or Wakefulness Disorders Neurodevelopmental Disorders: Attention-Deficit/Hyperactivity Disorder Eating Disorders Substance-Related Disorders Summary Case Studies Chapter 19. Drugs and Supplements to Enhance Performance Substances Banned for Competition Supplements for Enhancing Musculoskeletal Performance Supplements for Treating Neurological Conditions Supplements for Treating Skeletal Conditions Manipulation of Approved Medications to Enhance Performance Summary Case Studies Chapter 20. Cannabis and Cannabinoids Cannabis Cannabinoids Acute Effects of Cannabis Use Chronic Effects of Cannabis Use Adverse Effects of Cannabis Cannabidiol Medical Cannabinoids Research on Cannabinoid-Based Medicines Performance Effects and Sport Regulation Regulation of Cannabis Use Clinical Recommendations Summary Case Studies Chapter 21. Drug Testing in Sport Drug Education The Evolution of Drug Testing in Sport Supplement Standards The Drug-Testing Process Testing for Marijuana Testing for Anabolic Steroids Masking Agents Results of Drug Testing Drug Exemptions Summary Case Studies Chapter 22. Medications for Surgery Concepts of Anesthesia Effects of General Anesthesia Levels of Sedation Stages of Anesthesia Types of Anesthesia Common Applications of Anesthesia in Sports Medicine Preparation for a Surgical Procedure Recovery From a Surgical Procedure Adverse Effects of Anesthesia Summary Case Studies

Reviews

Author Information

Michelle Cleary, PhD, ATC, is an associate professor in the physician assistant studies program in the Crean College of Health and Behavioral Science at Chapman University. Prior to joining Chapman in 2012, Cleary taught at Temple University, where she earned her doctorate, and at Florida International University and the University of Hawaii. She is certified as an athletic trainer by the Board of Certification (BOC). She has 20 years of experience teaching in accredited athletic training programs. In addition to numerous journal articles and book chapters, Cleary has written two national position statements for the National Athletic Trainers’ Association (NATA), has served on several NATA committees, and received the Most Distinguished Athletic Trainer award from NATA in 2019. Cleary wrote Acute and Emergency Care in Athletic Training with Katie Walsh Flanagan. She is the chair of the Research and Grants Committee of the Far West Athletic Trainers’ Association and is also an active member of the California Athletic Trainers’ Association, receiving the Outstanding Service Award in 2015. Her clinical experience includes time as an athletic trainer at the high school, NCAA Division I, and international/Olympic levels. Thomas E Abdenour, DHSc, ATC, CES, received his doctorate degree in health science from A.T. Still University in 2011. He is a member of the National Athletic Trainers’ Association (NATA) and is currently on the NATA’s Foundation Board. Abdenour was inducted into the NATA Hall of Fame in 2007 and received the Most Distinguished Athletic Trainer award from NATA in 2014. He contributed to the 2009 NATA consensus statement Managing Prescription and Non-Prescription Medication in the Athletic Training Facility. Abdenour is best known for his work in the National Basketball Association, where he spent 23 years as the head athletic trainer for the Golden State Warriors. In 1990, he was recognized as the Athletic Trainer of the Year by the National Basketball Athletic Trainers Association. Abdenour served as athletic trainer for the gold-medal-winning USA men's basketball team at the 2000 Summer Olympics in Sydney, Australia. He also founded the Champion Guidance Center for Men in Oakland, California, to support underprivileged men. Following his time with the Golden State Warriors, he served as the head athletic trainer at San Diego State University. While at San Diego State University, he was an approved clinical instructor and an adjunct faculty member in the department of exercise and nutrition science. Michael Pavlovich, PharmD, earned his doctor of pharmacy degree in 1989 from the University of the Pacific. He is currently the president and owner of Westcliff Compounding Pharmacy. Pavlovich was an American Pharmacists Association (APhA) trustee from 2008 to 2014 and served in the APhA House of Delegates for more than 25 years. He received the Distinguished Achievement Award in Specialized Pharmacy Practice from APhA in 2012 and was recognized for his influence on the practice of pharmaceutical compounding and sports medicine. He is a past president of the California Pharmacists Association and a past board member of Pharmaceutical Care Network. Prior to his employment at Westcliff Compounding Pharmacy, Pavlovich was the chief pharmacist for SportPharm, which revolutionized athletic trainers’ capacity to manage prescription medications under the guidance of a team physician. He served as team pharmacist on the U.S. Olympic medical team at the 2008 Summer Olympics in Beijing, China. Pavlovich also contributed to the 2009 NATA consensus statement Managing Prescription and Non-Prescription Medication in the Athletic Training Facility. Many of his core recommendations for medication management in the athletic training clinic are still being followed today.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List